New Guidelines for Severe Community-acquired Pneumonia.

Journal

Seminars in respiratory and critical care medicine
ISSN: 1098-9048
Titre abrégé: Semin Respir Crit Care Med
Pays: United States
ID NLM: 9431858

Informations de publication

Date de publication:
01 Mar 2024
Historique:
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.

Identifiants

DOI: 10.1055/s-0043-1777797 PMID: 38428839
pubmed: 38428839
doi: 10.1055/s-0043-1777797
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Davide Calabretta (D)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Ignacio Martìn-Loeches (I)

Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland.
Trinity College Dublin, Dublin, Ireland.
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Department of Pulmonology, Hospital Clínic of Barcelona, Barcelona, Spain.

Antoni Torres (A)

Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
Department of Medicine, University of Barcelona, Barcelona, Spain.
Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

Classifications MeSH